What does DR. K. CLAEYSOONE do?

DR. K. CLAEYSOONE is a specialist medical practice in Turnhout. Private Limited, started on 2 July 2009, 1 establishment.

What is the address of DR. K. CLAEYSOONE?

The registered office of DR. K. CLAEYSOONE is located at Laguitstraat 5, 2300 Turnhout.

Is DR. K. CLAEYSOONE still active?

Yes. According to the CBE (30 October 2026) DR. K. CLAEYSOONE is active, legal situation “Normale toestand”, started on 2 July 2009.

Is DR. K. CLAEYSOONE registered on Peppol?

Yes, DR. K. CLAEYSOONE is registered on the Peppol network with ID 0208:0816903514.

What is the enterprise number of DR. K. CLAEYSOONE?

The enterprise number of DR. K. CLAEYSOONE is BE0816903514.

When was DR. K. CLAEYSOONE founded?

DR. K. CLAEYSOONE was founded on 2 July 2009.

Who are the directors of DR. K. CLAEYSOONE?

According to the 2025 annual accounts, the directors of DR. K. CLAEYSOONE are: Katarina Claeysoone.

Is DR. K. CLAEYSOONE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 July 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. K. CLAEYSOONE make in 2025?

DR. K. CLAEYSOONE posted a profit after taxes of € 198,115 in financial year 2025.

What is the revenue of DR. K. CLAEYSOONE?

As a small company, DR. K. CLAEYSOONE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 257,638.

DR. K. CLAEYSOONE (Private Limited) - Turnhout

Dossier DR. K. CLAEYSOONE, printed on 30 October 2026 from databakkes.be/en/0816903514/dr-k-claeysoone. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. K. CLAEYSOONE from Turnhout, company number BE0816903514, closed financial year 2025 with a result of € 198,115 after tax. For that financial year DR. K. CLAEYSOONE recorded a gross margin of € 257,638 and equity of € 939,365. Compared with financial year 2024, the result moved from € 176,016 to € 198,115. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 26, 2026.

What it is worth Growing

€ 939,365

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 198,115

▲ 13% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 324,858

▲ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 133,000 paid out

67 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 18,106

▼ 36% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,516

▼ 66% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 84,389

▲ 115% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 226,379 Gross margin 2022: € 226,379 First fiscal year in the series	€ 250,111 Gross margin 2023: € 250,111 ▲ 10% vs 2022 (€ 226,379) Favourable step	€ 266,955 Gross margin 2024: € 266,955 ▲ 7% vs 2023 (€ 250,111) Favourable step	€ 257,638 Gross margin 2025: € 257,638 ▼ 3% vs 2024 (€ 266,955) Unfavourable step	▼ 3%
Profit after taxes	€ 156,887 Profit after taxes 2022: € 156,887 First fiscal year in the series	€ 169,570 Profit after taxes 2023: € 169,570 ▲ 8% vs 2022 (€ 156,887) Favourable step	€ 176,016 Profit after taxes 2024: € 176,016 ▲ 4% vs 2023 (€ 169,570) Favourable step	€ 198,115 Profit after taxes 2025: € 198,115 ▲ 13% vs 2024 (€ 176,016) Favourable step	▲ 13%
Equity	€ 622,664 Equity 2022: € 622,664 First fiscal year in the series	€ 698,234 Equity 2023: € 698,234 ▲ 12% vs 2022 (€ 622,664) Favourable step	€ 874,251 Equity 2024: € 874,251 ▲ 25% vs 2023 (€ 698,234) Favourable step	€ 939,365 Equity 2025: € 939,365 ▲ 7% vs 2024 (€ 874,251) Favourable step	▲ 7%
Total debts	€ 148,668 Total debts 2022: € 148,668 First fiscal year in the series	€ 168,725 Total debts 2023: € 168,725 ▲ 13% vs 2022 (€ 148,668) Unfavourable step	€ 49,251 Total debts 2024: € 49,251 ▼ 71% vs 2023 (€ 168,725) Favourable step	€ 220,707 Total debts 2025: € 220,707 ▲ € 171,456 vs 2024 (€ 49,251) Unfavourable step	▲ € 171,456
Cash	€ 248,359 Cash 2022: € 248,359 First fiscal year in the series	€ 194,886 Cash 2023: € 194,886 ▼ 22% vs 2022 (€ 248,359) Unfavourable step	€ 272,403 Cash 2024: € 272,403 ▲ 40% vs 2023 (€ 194,886) Favourable step	€ 324,858 Cash 2025: € 324,858 ▲ 19% vs 2024 (€ 272,403) Favourable step	▲ 19%
Retained profit	€ 602,664 Retained profit 2022: € 602,664 First fiscal year in the series	€ 678,234 Retained profit 2023: € 678,234 ▲ 13% vs 2022 (€ 602,664) Favourable step	€ 854,251 Retained profit 2024: € 854,251 ▲ 26% vs 2023 (€ 678,234) Favourable step	€ 919,365 Retained profit 2025: € 919,365 ▲ 8% vs 2024 (€ 854,251) Favourable step	▲ 8%
Dividend	€ 79,500 Dividend 2022: € 79,500 First fiscal year in the series	€ 94,000 Dividend 2023: € 94,000 ▲ 18% vs 2022 (€ 79,500) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 94,000) Unchanged	€ 133,000 Dividend 2025: € 133,000 Unchanged (€ 0) Unchanged
Bank debt	€ 13,351 Bank debt 2022: € 13,351 First fiscal year in the series	€ 13,614 Bank debt 2023: € 13,614 ▲ 2% vs 2022 (€ 13,351) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 13,614) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 771,332 Balance sheet total 2022: € 771,332 First fiscal year in the series	€ 866,959 Balance sheet total 2023: € 866,959 ▲ 12% vs 2022 (€ 771,332) Unchanged	€ 923,502 Balance sheet total 2024: € 923,502 ▲ 7% vs 2023 (€ 866,959) Unchanged	€ 1,160,073 Balance sheet total 2025: € 1,160,073 ▲ 26% vs 2024 (€ 923,502) Unchanged	▲ 26%

Key figures of DR. K. CLAEYSOONE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. K. CLAEYSOONE?

What happened at DR. K. CLAEYSOONE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 26, 2026 New annual accounts for financial year 2025: profit of € 198,115 (▲ 13% vs 2024). Source: NBB ↗
Jul 2, 2009 New establishment in Turnhout. KBO
Jul 2, 2009 Start of the company according to the CBE. KBO

In short

From € 156,887 profit in 2022 to € 198,115 profit in 2025.

Paid € 317,026 in corporate taxes since 2022.

Best year ever: 2025, with € 198,115 profit.

Paid out € 306,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Katarina Claeysoone

DR. K. CLAEYSOONE

Behind DR. K. CLAEYSOONE is Katarina Claeysoone.

Directors

According to the 2025 annual accounts

Katarina Claeysoone

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Laguitstraat 5

2300 Turnhout

2.179.389.961

Rubensstraat 166

2300 Turnhout

Active since 2 July 2009

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0816.903.514
VAT number: BE 0816.903.514
Registered office: Laguitstraat 5, 2300 Turnhout
Names & denominations: DR. K. CLAEYSOONE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 2 July 2009
Peppol: Active · Active since 20 May 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗